Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein

Microb Cell Fact. 2017 Dec 12;16(1):223. doi: 10.1186/s12934-017-0837-z.

Abstract

Background: A key advantage of recombinant antibody technology is the ability to optimize and tailor reagents. Single domain antibodies (sdAbs), the recombinantly produced variable domains derived from camelid and shark heavy chain antibodies, provide advantages of stability and solubility and can be further engineered to enhance their properties. In this study, we generated sdAbs specific for Ebola virus envelope glycoprotein (GP) and increased their stability to expand their utility for use in austere locals. Ebola virus is extremely virulent and causes fatal hemorrhagic fever in ~ 50 percent of the cases. The viral GP binds to host cell receptors to facilitate viral entry and thus plays a critical role in pathogenicity.

Results: An immune phage display library containing more than 107 unique clones was developed from a llama immunized with a combination of killed Ebola virus and recombinantly produced GP. We panned the library to obtain GP binding sdAbs and isolated sdAbs from 5 distinct sequence families. Three GP binders with dissociation constants ranging from ~ 2 to 20 nM, and melting temperatures from ~ 57 to 72 °C were selected for protein engineering in order to increase their stability through a combination of consensus sequence mutagenesis and the addition of a non-canonical disulfide bond. These changes served to increase the melting temperatures of the sdAbs by 15-17 °C. In addition, fusion of a short positively charged tail to the C-terminus which provided ideal sites for the chemical modification of these sdAbs resulted in improved limits of detection of GP and Ebola virus like particles while serving as tracer antibodies.

Conclusions: SdAbs specific for Ebola GP were selected and their stability and functionality were improved utilizing protein engineering. Thermal stability of antibody reagents may be of particular importance when operating in austere locations that lack reliable refrigeration. Future efforts can evaluate the potential of these isolated sdAbs as candidates for diagnostic or therapeutic applications for Ebola.

Keywords: Antibody engineering; Ebola virus; Glycoprotein; Single domain antibodies; Virus like particles.

MeSH terms

  • Animals
  • Camelids, New World
  • Ebolavirus / chemistry
  • Ebolavirus / immunology*
  • Hemorrhagic Fever, Ebola / diagnosis
  • Hemorrhagic Fever, Ebola / therapy
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin Heavy Chains / immunology
  • Immunoglobulin Heavy Chains / isolation & purification
  • Immunoglobulin Heavy Chains / metabolism
  • Peptide Library
  • Protein Binding
  • Protein Engineering / methods*
  • Protein Stability*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism
  • Refrigeration
  • Single-Domain Antibodies / genetics
  • Single-Domain Antibodies / immunology*
  • Single-Domain Antibodies / isolation & purification*
  • Single-Domain Antibodies / metabolism
  • Temperature
  • Viral Envelope Proteins / chemistry
  • Viral Envelope Proteins / immunology*

Substances

  • Immunoglobulin Heavy Chains
  • Peptide Library
  • Recombinant Proteins
  • Single-Domain Antibodies
  • Viral Envelope Proteins
  • envelope glycoprotein, Ebola virus